N Galai

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. pmc Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs
    Bernadette Anna Mullen
    Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    BMC Infect Dis 11:45. 2011
  2. ncbi request reprint Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras
    Noya Galai
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 38:74-81. 2005
  3. ncbi request reprint Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants
    N Galai
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 158:695-704. 2003
  4. ncbi request reprint Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective
    S A Strathdee
    Department of Epidemiology, Johns Hopkins School of Public Health, 615 N Wolfe St, Room E6010, Baltimore, MD 21205, USA
    Arch Intern Med 161:1281-8. 2001
  5. ncbi request reprint Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
    D D Celentano
    Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205, USA
    AIDS 15:1707-15. 2001
  6. pmc The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users
    Thomas Alex Washington
    Drug Abuse Research Program, Morgan State University, Baltimore, Maryland 21251, USA
    Arch Sex Behav 35:67-74. 2006
  7. ncbi request reprint Mortality risk among new onset injection drug users
    David Vlahov
    Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Addiction 99:946-54. 2004
  8. ncbi request reprint Factors associated with recent-onset injection drug use among drug users in Pakistan
    Irene Kuo
    Department of Epidemiology and Biostatistics, George Washington University School of Public Health and Health Services, Washington, DC, USA
    Subst Use Misuse 42:853-70. 2007
  9. ncbi request reprint HIV incidence among injection drug users in Baltimore, Maryland (1988-2004)
    Shruti H Mehta
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 43:368-72. 2006
  10. ncbi request reprint HIV infection is associated with an increased risk for lung cancer, independent of smoking
    Gregory D Kirk
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Clin Infect Dis 45:103-10. 2007

Collaborators

Detail Information

Publications33

  1. pmc Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs
    Bernadette Anna Mullen
    Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    BMC Infect Dis 11:45. 2011
    ..Prior work from our group and others suggests that directly administered antiretroviral therapy (DAART) delivered in opioid treatment programs (OTPs) may increase rates of viral suppression...
  2. ncbi request reprint Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras
    Noya Galai
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 38:74-81. 2005
    ..Clinical and behavioral variables provided prognostic information about survival, including substance use indicators...
  3. ncbi request reprint Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants
    N Galai
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 158:695-704. 2003
    ..This view emphasizes the need for prolonged efforts to sustain cessation and to prevent adverse health and social outcomes among injection drug users...
  4. ncbi request reprint Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective
    S A Strathdee
    Department of Epidemiology, Johns Hopkins School of Public Health, 615 N Wolfe St, Room E6010, Baltimore, MD 21205, USA
    Arch Intern Med 161:1281-8. 2001
    ..Prospective studies that investigate both sexual and parenteral HIV risks among injection drug users (IDUs) are needed. We studied factors for HIV seroconversion among male and female IDUs in Baltimore, Md...
  5. ncbi request reprint Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
    D D Celentano
    Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205, USA
    AIDS 15:1707-15. 2001
    ..We assess factors associated with initiating highly active antiretroviral therapy (HAART) in HIV-infected IDUs...
  6. pmc The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users
    Thomas Alex Washington
    Drug Abuse Research Program, Morgan State University, Baltimore, Maryland 21251, USA
    Arch Sex Behav 35:67-74. 2006
    ..Furthermore, men reporting inconsistent sexual orientation tended to engage in higher risk behaviors, suggesting that these men should be especially targeted for interventions...
  7. ncbi request reprint Mortality risk among new onset injection drug users
    David Vlahov
    Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Addiction 99:946-54. 2004
    ..To characterize mortality experience among those who only recently started injection...
  8. ncbi request reprint Factors associated with recent-onset injection drug use among drug users in Pakistan
    Irene Kuo
    Department of Epidemiology and Biostatistics, George Washington University School of Public Health and Health Services, Washington, DC, USA
    Subst Use Misuse 42:853-70. 2007
    ..Familial/social influences were also associated with recent-onset injection, suggesting peer-led interventions could discourage transition to injection drug use...
  9. ncbi request reprint HIV incidence among injection drug users in Baltimore, Maryland (1988-2004)
    Shruti H Mehta
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 43:368-72. 2006
    ..We examined recent trends (1999-2004) in HIV incidence among a cohort of injection drug users (IDUs) followed since 1988 in Baltimore, Maryland...
  10. ncbi request reprint HIV infection is associated with an increased risk for lung cancer, independent of smoking
    Gregory D Kirk
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Clin Infect Dis 45:103-10. 2007
    ..Human immunodeficiency virus (HIV)-infected persons have an elevated risk for lung cancer, but whether the increase reflects solely their heavy tobacco use remains an open question...
  11. ncbi request reprint HIV infection in young men in northern Thailand, 1991-1998: increasing role of injection drug use
    Kenrad E Nelson
    Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland 21205, USA
    J Acquir Immune Defic Syndr 29:62-8. 2002
    ..Nevertheless, injection drug use has emerged as an important risk behavior and is maintaining endemic HIV transmission in Thailand...
  12. ncbi request reprint Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy
    Cunlin Wang
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
    J Infect Dis 190:1046-54. 2004
    ..The optimal time to initiate highly active antiretroviral therapy (HAART) remains unclear...
  13. pmc Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    Clin Infect Dis 50:1664-71. 2010
    ..We characterized temporal trends in highly active antiretroviral therapy (HAART) initiation (1996-2008) among treatment-eligible persons in a community-based cohort of current and former injection drug users (IDUs) in Baltimore, Maryland...
  14. ncbi request reprint High HIV prevalence and risk behaviors in men who have sex with men in Chennai, India
    Vivian F Go
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 35:314-9. 2004
    ..To estimate HIV and sexually transmitted disease (STD) prevalence and behavioral risk characteristics of men who have sex with men (MSM) in Chennai, India...
  15. ncbi request reprint Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998
    Kenrad E Nelson
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 156:641-53. 2002
    ..These data suggest that high-risk behavior and HIV incidence among IDUs have decreased recently in Baltimore. Nevertheless, additional prevention strategies are needed in these populations...
  16. ncbi request reprint Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users
    S H Mehta
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    AIDS Care 19:637-45. 2007
    ..Interventions to reduce treatment interruptions and to provide continuity of HIV care during incarceration among IDUs are needed to improve responses and subsequent survival...
  17. ncbi request reprint Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore
    Richard D Semba
    Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Am J Drug Alcohol Abuse 33:71-80. 2007
    ..Women lost to follow-up were younger, more often white, not on methadone, and injecting drugs daily. Fair-moderate adherence to visits and treatment occurs among female IDUs in a clinical trial...
  18. pmc Nonstructured treatment interruptions among injection drug users in Baltimore, MD
    Ravi Kavasery
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 50:360-6. 2009
    ..We characterized patterns of highly active antiretroviral therapy (HAART) use and predictors of nonstructured treatment interruptions (NTIs) among injection drug users (IDUs) in Baltimore, MD...
  19. ncbi request reprint The effect of HIV infection on overdose mortality
    Cunlin Wang
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    AIDS 19:935-42. 2005
    ..To quantify the association of HIV infection with overdose mortality and explore the potential mechanisms...
  20. ncbi request reprint End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004
    Gregory M Lucas
    Department of Medicine, Divisions of Infectious Diseases, Bloomberg School of Public Health, John Hopkins University, Baltimore, Maryland, USA
    AIDS 21:2435-43. 2007
    ..HIV-infected African-Americans are at increased risk of end-stage renal disease requiring renal replacement therapy (RRT)...
  21. pmc Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study
    Michelle Shardell
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, USA
    Am J Epidemiol 168:1460-9. 2008
    ....
  22. pmc Inference for cumulative incidence functions with informatively coarsened discrete event-time data
    Michelle Shardell
    Department of Epidemiology and Preventive Medicine, University of Maryland, 660 West Redwood Street, Baltimore, MD 21201 1596, USA
    Stat Med 27:5861-79. 2008
    ....
  23. pmc Effect of menses on clearance of Y-chromosome in vaginal fluid: implications for a biomarker of recent sexual activity
    Rebecca M Brotman
    Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
    Sex Transm Dis 37:1-4. 2010
    ..In this study, we found menses results in lower Y-chromosome concentrations but with similar decay patterns as non-menstrual samples...
  24. ncbi request reprint Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: preliminary studies of a potential biomarker for sexual behavior
    Jonathan M Zenilman
    Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Sex Transm Dis 32:90-4. 2005
    ..Self-reported measures of sexual behavior are subject to nontrivial reporting biases...
  25. ncbi request reprint Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection
    Sadeep Shrestha
    Laboratory of Genomic Diversity, National Cancer Institute at Frederick, National Institutes of Health, MD 21702, USA
    J Infect Dis 193:16-26. 2006
    ..The matched case-control study design with measured risk exposures provides an avenue for discovering genes involved in susceptibility to infection...
  26. ncbi request reprint Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection
    David Vlahov
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY 10029, USA
    Am J Epidemiol 161:999-1012. 2005
    ..37/microl, respectively), suggesting that changing indications for treatment may have contributed to improved survival and that analyses restricted to the HAART era probably underestimate HAART effectiveness...
  27. ncbi request reprint Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000
    Nina G Shah
    Epidemiology and Response Division, New Mexico Department of Health, 1190 St Francis Drive, P O Box 26110, Santa Fe, NM 87502 6110, USA
    Drug Alcohol Depend 83:147-56. 2006
    ..To determine predictors of injection drug use cessation and subsequent relapse among a cohort of injection drug users (IDUs)...
  28. doi request reprint Effect of infections on 30-day mortality among critically ill patients hospitalized in and out of the intensive care unit
    George Mnatzaganian
    Department of Health Services Research, Ministry of Health, Jerusalem, Israel
    Crit Care Med 36:1097-104. 2008
    ..This analysis is part of a multicenter study conducted in Israel to evaluate survival of critically ill patients treated in and out of intensive care units (ICUs)...
  29. ncbi request reprint Survival of critically ill patients hospitalized in and out of intensive care
    Elisheva Simchen
    Department of Health Services Research, Ministry of Health, Jerusalem, Israel
    Crit Care Med 35:449-57. 2007
    ..The survival of such patients is largely unknown. The present study's objective was to screen entire hospitals for newly deteriorated patients and compare their survival in and out of the intensive care unit...
  30. pmc Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples
    Lena Novack
    Department of Epidemiology and Health Services Evaluation, Ben Gurion University of the Negev, P O Box 653, Beer Sheva 84105, Israel
    J Clin Microbiol 44:2909-13. 2006
    ..ELISA screening of pooled samples could be considered in settings where the testing of blood supplies for HIV is not routinely done...
  31. ncbi request reprint Respiratory complaints and medication use following cessation of exposure to construction dust and diesel truck emissions (Neve Yakov, Jerusalem)
    Zhaneta Gabrovska
    Hebrew University Hadassah School of Community Medicine and Public Health, Unit of Occupational and Environmental Medicine, Jerusalem, Israel
    Int J Occup Med Environ Health 17:441-9. 2004
    ..The aim of the study was to assess respiratory complaints in the residents of Neve Yakov following the closure of a municipal dump, operating in the neighborhood for 3 years...
  32. ncbi request reprint Survival of critically ill patients hospitalized in and out of intensive care units under paucity of intensive care unit beds
    Elisheva Simchen
    Department of Health Services Research, Ministry of Health, Jerusalem, Israel
    Crit Care Med 32:1654-61. 2004
    ..The object was to screen entire hospital patient populations for critically ill patients and compare their 30-day survival in and out of the intensive care unit...
  33. ncbi request reprint Treatment of intestinal worms is associated with decreased HIV plasma viral load
    Dawit Wolday
    Armauer Hansen Research Institute, Addis Ababa, Ethiopia
    J Acquir Immune Defic Syndr 31:56-62. 2002
    ..We have previously suggested that helminthic infections make the host more susceptible to HIV infection and enhance its progression due to the chronic immune activation they cause...